102 related articles for article (PubMed ID: 35837707)
1. Updated concepts in treatment of giant cell tumor of bone.
van der Heijden L; Lipplaa A; van Langevelde K; Bovée JVMG; van de Sande MAJ; Gelderblom H
Curr Opin Oncol; 2022 Jul; 34(4):371-378. PubMed ID: 35837707
[TBL] [Abstract][Full Text] [Related]
2. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.
Tsukamoto S; Mavrogenis AF; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Errani C
Curr Oncol; 2024 Apr; 31(4):2112-2132. PubMed ID: 38668060
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
[TBL] [Abstract][Full Text] [Related]
4. Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis.
Tan X; Zhang Y; Wei D; Yang Y; Xiang F
Clin Exp Med; 2023 Nov; 23(7):3053-3075. PubMed ID: 37103655
[TBL] [Abstract][Full Text] [Related]
5. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
[TBL] [Abstract][Full Text] [Related]
6. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
Arefpour A; Shafieesabet M; Chehrassan M; Ahmadzadehnanva A; Ghandhari H
Musculoskelet Surg; 2024 Mar; 108(1):93-98. PubMed ID: 37940782
[TBL] [Abstract][Full Text] [Related]
7. Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study.
Lipplaa A; Schreuder WH; Pichardo SEC; Gelderblom H
Oncologist; 2023 Nov; 28(11):1005-e1104. PubMed ID: 37449658
[TBL] [Abstract][Full Text] [Related]
8. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation.
Lejoly M; Van Den Berghe T; Creytens D; Huysse W; Lapeire L; Sys G; Verstraete K
Skeletal Radiol; 2024 Feb; 53(2):353-364. PubMed ID: 37515643
[TBL] [Abstract][Full Text] [Related]
10. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review.
Sereno M; Franco SR; de la Reina L; Campo-Cañaveral de la Cruz JL; Muñoz de Legaría M; Casado Saénz E
Curr Oncol; 2023 Oct; 30(10):9335-9345. PubMed ID: 37887575
[TBL] [Abstract][Full Text] [Related]
11. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
[TBL] [Abstract][Full Text] [Related]
12. Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy.
Xiang F; Liu H; Deng J; Ma W; Chen Y
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497239
[TBL] [Abstract][Full Text] [Related]
13. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract][Full Text] [Related]
14. The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract][Full Text] [Related]
15. Denosumab treatment for progressive Enneking stage II cervical giant-cell tumor conservatively.
Tan Y; Zhang S; Zhang J; Huang T; Li X; Zhou X; Zhang J
Funct Integr Genomics; 2023 Mar; 23(1):76. PubMed ID: 36867323
[TBL] [Abstract][Full Text] [Related]
16. Current indications for denosumab in benign bone tumours.
Imre A; Zoltán S; Miklós S
EFORT Open Rev; 2023 Dec; 8(12):895-905. PubMed ID: 38038377
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone.
Metovic J; Annaratone L; Linari A; Osella-Abate S; Musuraca C; Veneziano F; Vignale C; Bertero L; Cassoni P; Ratto N; Comandone A; Grignani G; Piana R; Papotti M
Cancer Immunol Immunother; 2020 Sep; 69(9):1905-1916. PubMed ID: 32377818
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
[TBL] [Abstract][Full Text] [Related]
19. Histological and immunohistochemical analyses of osteoclast maturation in giant cell tumor of bone.
Agawa R; Kato I; Kawabata Y; Takeyama M; Fujii S
Pathol Res Pract; 2024 Feb; 254():155128. PubMed ID: 38244437
[TBL] [Abstract][Full Text] [Related]
20. Management of a rare mandibular giant cell tumor of bone by neoadjuvant denosumab therapy and surgery: A 4-year follow-up case report.
Klienkoff P; Weingertner N; Geyer L; Gros CI; Kurtz JE; Bornert F
Int J Surg Case Rep; 2023 Nov; 112():108980. PubMed ID: 37913666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
